Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001415889-22-008894

CHIEF LEGAL OFFICER bought 300,000 shares at $0.17 ($50,910)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Adler Reid G. CHIEF LEGAL OFFICER 2022-08-17 Purchase +300,000 $0.17 $50,910 334,629 D
Open-market purchases · 300,000 sh · avg $0.17 · $50,910
Loading xslF345X03/form4-08192022_030801.xml…